Tel-Array endeavours to transform disease diagnoses from the central laboratory setting to the point-of-care through the development and commercialization of a series of immunoassay-based molecular diagnostic tests and devices. Multiple biomarkers can be simultaneously quantified from a single test sample with the use of protein microarrays. Initial areas of application: cardiac markers, cancer markers.